Ji-Seon Park

Title: Ji-Seon Park: Innovator in Pharmaceutical Chemistry

Introduction

Ji-Seon Park is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on addressing critical health issues through innovative solutions.

Latest Patents

Ji-Seon Park holds a patent for a tricyclic derivative or pharmaceutically acceptable salts thereof, along with its preparation method and pharmaceutical composition. This invention relates to a novel tricyclic derivative that exhibits efficient inhibitory activity against poly(ADP-ribose) polymerases (PARP). The tricyclic derivative is particularly useful for the prevention or treatment of diseases caused by excess PARP activity, including neuropathic pain, neurodegenerative diseases, cardiovascular diseases, diabetic nephropathy, inflammatory diseases, osteoporosis, and cancer. By inhibiting the activity of PARP, this invention offers promising therapeutic potential.

Career Highlights

Ji-Seon Park is associated with Je Il Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to tackling complex medical challenges.

Collaborations

Ji-Seon Park collaborates with esteemed colleagues, including Myung-Hwa Kim and Seung-Hyun Kim, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the pharmaceutical field.

Conclusion

Ji-Seon Park's contributions to pharmaceutical chemistry exemplify the importance of innovation in addressing health challenges. His patented tricyclic derivative represents a significant advancement in the treatment of various diseases, showcasing the potential of targeted therapies.